Anderson F - Search Results

1

Palliative performance scale (PPS): a new tool.

Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Anderson F, et al. J Palliat Care. 1996 Spring;12(1):5-11. J Palliat Care. 1996. PMID: 8857241

2

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.

Hsu PC, Federico CA, Krajden M, Yoshida EM, Bremner KE, Anderson FH, Weiss AA, Krahn MD. Hsu PC, et al. J Gastroenterol Hepatol. 2012 Jan;27(1):149-57. doi: 10.1111/j.1440-1746.2011.06813.x. J Gastroenterol Hepatol. 2012. PMID: 21679248

3

Does cirrhosis affect quality of life in hepatitis C virus-infected patients?

Hsu PC, Krajden M, Yoshida EM, Anderson FH, Tomlinson GA, Krahn MD. Hsu PC, et al. Liver Int. 2009 Mar;29(3):449-58. doi: 10.1111/j.1478-3231.2008.01865.x. Liver Int. 2009. PMID: 19267865

4

Attempted resolution of acute recurrent hepatitis B in a transplanted liver allograft by the administration of ganciclovir.

Yoshida EM, Wolber RA, Mahmood WA, Anderson FH, Scudamore CH, Erb SR. Yoshida EM, et al. Among authors: anderson fh. Transplantation. 1994 Oct 27;58(8):956-8. doi: 10.1097/00007890-199410270-00019. Transplantation. 1994. PMID: 7940744 No abstract available.

5

Evaluation of VCH-759 monotherapy in hepatitis C infection.

Cooper C, Lawitz EJ, Ghali P, Rodriguez-Torres M, Anderson FH, Lee SS, Bédard J, Chauret N, Thibert R, Boivin I, Nicolas O, Proulx L. Cooper C, et al. J Hepatol. 2009 Jul;51(1):39-46. doi: 10.1016/j.jhep.2009.03.015. Epub 2009 Apr 23. J Hepatol. 2009. PMID: 19446909 Clinical Trial.

6

Seasonal change in the exacerbations of Crohn's disease.

Zeng L, Anderson FH. Zeng L, et al. Among authors: anderson fh. Scand J Gastroenterol. 1996 Jan;31(1):79-82. doi: 10.3109/00365529609031631. Scand J Gastroenterol. 1996. PMID: 8927945

7

Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.

Al Faraidy K, Yoshida EM, Davis JE, Vartanian RK, Anderson FH, Steinbrecher UP. Al Faraidy K, et al. Among authors: anderson fh. Transplantation. 1997 Sep 27;64(6):926-8. doi: 10.1097/00007890-199709270-00024. Transplantation. 1997. PMID: 9326423

8

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.

Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, Jacobson IM; SPRINT-2 Trial Investigators. Sulkowski MS, et al. Hepatology. 2013 Mar;57(3):974-84. doi: 10.1002/hep.26096. Epub 2013 Feb 11. Hepatology. 2013. PMID: 23081753 Clinical Trial.

9

Patient time costs and out-of-pocket costs in hepatitis C.

Federico CA, Hsu PC, Krajden M, Yoshida EM, Bremner KE, Weiss AA, Anderson FH, Krahn MD. Federico CA, et al. Liver Int. 2012 May;32(5):815-25. doi: 10.1111/j.1478-3231.2011.02722.x. Epub 2012 Jan 3. Liver Int. 2012. PMID: 22221745

10

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

John-Baptiste AA, Tomlinson G, Hsu PC, Krajden M, Heathcote EJ, Laporte A, Yoshida EM, Anderson FH, Krahn MD. John-Baptiste AA, et al. Am J Gastroenterol. 2009 Oct;104(10):2439-48. doi: 10.1038/ajg.2009.346. Epub 2009 Jun 30. Am J Gastroenterol. 2009. PMID: 19568230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

909 results

Search Page